Research programme: antifungals - Aurigene Oncology/Pcovery
Latest Information Update: 15 Jan 2024
At a glance
- Originator Pcovery
- Developer Aurigene Oncology; Pcovery
- Class
- Mechanism of Action Membrane protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Mycoses in Denmark
- 23 Apr 2014 Research programme is ongoing in Denmark
- 09 Sep 2010 Early research in Mycoses in Denmark (unspecified route)